ConductScience.org, home

Gene · 27063

ANKRD1: ankyrin repeat domain 1

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. ANKRD1: ankyrin repeat domain 1. Genes, record 27063. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/27063

On this page

Gene

Symbol
ANKRD1
HGNC
Name
ankyrin repeat domain 1
HGNC
NCBI Gene ID
27063
NCBI Gene
HGNC ID
HGNC:15819
HGNC
Ensembl
ENSG00000148677
NCBI Gene
Aliases
ALRP, C-193, CARP, CVARP, MCARP, bA320F15.2
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q15327Ankyrin repeat domain-containing protein 13190Ensembl, GeneID, HGNC

Source UniProt

Patents26

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
WO 2026017877 A12026-01-224Q15327Espacenet
EP 4650780 A22025-11-198997Q15327Espacenet
EP 4641201 A22025-10-299237Q15327Espacenet
JP 2025517969 A2025-06-129237Q15327Espacenet
JP 2025517970 A2025-06-128997Q15327Espacenet
JP 2025062604 A2025-04-145120Q15327Espacenet
US 11564998 B22023-01-316281Q15327Espacenet
JP 2023503301 A2023-01-276Q15327Espacenet
US 11446398 B22022-09-205120Q15327Espacenet
JP 2022524081 A2022-04-27108091Q15327Espacenet

1 to 10 of 26

See all 26 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants974

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleANKRD1 papersNewest fiscal year
P30CA016672Cancer Center Support Grant52025
P30CA016056Roswell Park Cancer Center Support Grant42025
P30CA008748Cancer Center Support Grant32025
P51OD011092Support for National Primate Research Center32025
R35GM146865Methods and approaches to expand the pharmacological toolset32025
R35HL144998Role of the giant protein titin in cardiac health and disease32025
R35HL161185Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart Failure32025
UL1TR001863Yale Clinical and Translational Science Award32025
K08EY031755Investigating mechanosensation in the glaucomatous optic nerve head22025
P01CA120964Molecular Pathogenesis of the Hamartoma Syndromes22025

1 to 10 of 974Source NIH's project files

See all 974 nih grants

Papers1,313

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Honokiol Suppresses Stemness and Sensitizes Triple-Negative Breast Cancer to Chemotherapy via YAP/TAZ-TEAD Inhibition.Oncol Res202642769416PubTator, text miningPubMed
Transcriptomic Profile of Genes Regulating Cellular Response to Extra- and Intracellular Stimuli in Porcine Ovarian Granulosa Cells During In Vitro Cultivation.Int J Mol Sci202642353161PubTator, text miningPubMed
Beta-Adrenergic Stimulation and MYH7 G256E Mutant Gene Dosage Drive Hypertrophic Cardiomyopathy Phenotype Penetrance.bioRxiv202642282692PubTator, text miningPubMed
Solamargine alleviates liver fibrosis by regulating YAP signaling in hepatic stellate cells.Zhong Nan Da Xue Xue Bao Yi Xue Ban202642244286PubTator, text miningPubMed
Variant-to-function dissection of the 17q21.31 locus resolves ANKRD1 as a convergent regulatory target.BMC Med Genomics202642057133PubTator, text miningPubMed
Epigenetic remodeling in sarcoma promotes T-cell infiltration via modulation of the Hippo pathway.J Immunother Cancer202641922083PubTator, text miningPubMed
Obesity and Cancer: From Systemic Metabolic Reprogramming to Immunotherapy Paradox.Metabolites202641893325PubTator, text miningPubMed
Leveraging Large and Diverse Biobanks to Evaluate Gene-Disease Associations in Hypertrophic Cardiomyopathy.J Pers Med202641893039PubTator, text miningPubMed
Yifei Sanjie pill combined with gefitinib reduces the progression of EGFR-TKIs-resistant non-small cell lung cancer via YAP/ANKRD1 axis.Phytomedicine202641865688PubTator, text miningPubMed
GFPT2 drives sunitinib resistance of renal cell carcinoma via enzyme-dependent and -independent manners.Int J Biol Sci202641800253PubTator, text miningPubMed

1 to 10 of 1,313

See all 1,313 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/27063

GET https://conductscience.org/api/genes/v1/27063/patents?page=2